TY  - JOUR 
AU  - Labrador, Jorge
AU  - Saiz Rodríguez, Miriam
AU  - de Miguel, Dunia
AU  - de Laiglesia, Almudena
AU  - Rodríguez Medina, Carlos
AU  - Vidriales, María Belén
AU  - Pérez Encinas, Manuel
AU  - Sánchez Sánchez, María José
AU  - Cuello, Rebeca
AU  - Roldán Pérez, Alicia
AU  - Vives, Susana
AU  - Benzo Callejo, Gonzalo
AU  - Colorado, Mercedes
AU  - García Fortes, María
AU  - Sayas, María José
AU  - Olivier, Carmen
AU  - Recio, Isabel
AU  - Conde Royo, Diego
AU  - Bienert García, Álvaro
AU  - Vahi, María
AU  - Muñoz García, Carmen
AU  - Seri Merino, Cristina
AU  - Tormo, Mar
AU  - Vall llovera, Ferran
AU  - Foncillas, María Ángeles
AU  - Martínez Cuadrón, David
AU  - Sanz, Miguel Ángel
AU  - Montesinos, Pau
PY  - 2022
UR  - https://hdl.handle.net/10259/12199
AB  - The effectiveness of venetoclax (VEN) in relapsed or refractory acute myeloid leukemia (RR-AML) has not been well established. This retrospective, multicenter, observational database studied the effectiveness of VEN in a cohort of 51 RR-AML patients...
LA  - eng
PB  - MDPI
KW  - Venetoclax
KW  - Acute myeloid leukemia
KW  - Relapsed
KW  - Refractory
KW  - Leucemia mieloide aguda
KW  - Acute myeloid leukemia
TI  - Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
DO  - 10.3390/CANCERS14071734
T2  - Cancers
VL  - 14
M2  - 1734
ER  -